Sfoglia per Autore
Metronomic 5-Fluorouracil and Vinorelbine Reduce Cancer Stemness and Modulate EZH2/NOTCH-1/STAT3 Signaling in Triple-Negative Breast Cancer Spheroids
2026 Ilari, A; Grassilli, E; Mauri, M; Cazzaniga, M; Capici, S; Lavitrano, M; Cerrito, M
Toward a unified approach: Considerations for bioinformatic and sequencing activities & data in wastewater surveillance of biologic public health threats
2026 Psomopoulos, F; O'Cathail, C; Anastasiadou, N; Cocuzza, C; Cuypers, W; Idowu, O; Kyritsis, K; Lauer, K; Lavitrano, M; Leoni, G; Liu, J; Macori, G; Mannara', G; Manuel, D; Martinelli, M; Musumeci, R; Neves, A; Pechlivanis, N; Petrillo, M; Ragoussis, J; Rahman, N; Öjefors Stark, K; Thomson, M; Wade, M; Wright, M
Blood derived extracellular vesicles in patients with glioblastoma: preliminary experience from a monoinstitutional series
2026 Di Cristofori, A; Ghizzi, M; Raimondo, F; Ramponi, A; Cimino, A; Giambra, M; Graziano, F; Basso, G; Lavitrano, M; Carrabba, G; Giussani, C; Bentivegna, A
Implementation of a Digital Maturity Framework for Biobanking
2025 Rossi, F; Fragnito, D; Cruoglio, A; Palombo, R; Massacci, A; Sulis, A; Meloni, V; Casati, S; Mirabile, A; Manconi, A; Milanesi, L; Ciliberto, G; Forni, M; Adami, V; Borsani, M; Miele, C; Lavitrano, M; Pallocca, M
Riluzole inhibits ovarian cancer cell migration by altering extracellular matrix structure
2025 Villa, C; Duranti, E; Cadamuro, M; Lavitrano, M
TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy
2025 Bonomo, S; Giovannoni, R; Lavitrano, M; Cadamuro, M; Conconi, D
Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases
2025 Yashooa, R; Duranti, E; Conconi, D; Lavitrano, M; Mustafa, S; Villa, C
Wastewater Surveillance for SARS-CoV-2 in Northern Italy: An Evaluation of Three Different Gene Targets
2025 Mannara', G; Martinelli, M; Giubbi, C; Rizza, M; Giordano, E; Perdoni, F; Bruno, E; Morella, A; Azzellino, A; Turolla, A; Pedrini, R; Malpei, F; La Rosa, G; Suffredini, E; Cereda, D; Ammoni, E; Villa, S; Pregnolato, F; Lavitrano, M; Franzetti, A; Musumeci, R; Cocuzza, C
TIMP1 Overexpression in Ovarian Cancer Spheroids: Implications for Prognosis, Resistance, and Metastatic Potential
2025 Jemma, A; Ardizzoia, A; Villa, C; Bonomo, S; Mauri, M; Reale, C; Ambrosino, C; Cadamuro, M; Lavitrano, M; Conconi, D
Prognostic Relevance of Copy Number Losses in Ovarian Cancer
2024 Jemma, A; Ardizzoia, A; Redaelli, S; Bentivegna, A; Lavitrano, M; Conconi, D
Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells
2024 Giambra, M; Di Cristofori, A; Raimondo, F; Rigolio, R; Conconi, D; Chiarello, G; Tabano, S; Antolini, L; Nicolini, G; Bua, M; Ferlito, D; Carrabba, G; Giussani, C; Lavitrano, M; Bentivegna, A
Olfactory receptor genes and chromosome 11 structural aberrations: Players or spectators?
2024 Redaelli, S; Grati, F; Tritto, V; Giannuzzi, G; Recalcati, M; Sala, E; Villa, N; Crosti, F; Roversi, G; Malvestiti, F; Zanatta, V; Repetti, E; Rodeschini, O; Valtorta, C; Catusi, I; Romitti, L; Martinoli, E; Conconi, D; Dalprà, L; Lavitrano, M; Riva, P; Bentivegna, A
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer
2024 Ilari, A; Cogliati, V; Sherif, N; Grassilli, E; Ramazzotti, D; Cordani, N; Cazzaniga, G; Di Bella, C; Lavitrano, M; Cazzaniga, M; Cerrito, M
Cytogenetically Balanced Reciprocal Translocation Could Hide Molecular Genomic Unbalances: Implications for Foetal Phenotype Correlation
2024 Villa, N; Redaelli, S; Farina, S; Sala, E; Crosti, F; Cozzolino, S; Verderio, M; Dalpra, L; Roversi, G; Bentivegna, A; Cazzaniga, G; Lavitrano, M; Conconi, D
Unveiling Inter- and Intra-Patient Sequence Variability with a Multi-Sample Coronavirus Target Enrichment Approach
2024 Lado, S; Thannesberger, J; Spettel, K; Arapovic, J; Ferreira, B; Lavitrano, M; Steininger, C
AI drives the assessment of lung cancer microenvironment composition
2024 Gallo, E; Guardiani, D; Betti, M; Arteni, B; Di Martino, S; Baldinelli, S; Daralioti, T; Merenda, E; Ascione, A; Visca, P; Pescarmona, E; Lavitrano, M; Nisticò, P; Ciliberto, G; Pallocca, M
High-sensitivity analysis of clonal hematopoiesis reveals increased clonal complexity of potential-driver mutations in severe COVID-19 patients
2024 Ronchini, C; Caprioli, C; Tunzi, G; D'Amico, F; Colombo, E; Giani, M; Foti, G; Conconi, D; Lavitrano, M; Passerini, R; Pase, L; Capizzi, S; Mastrilli, F; Alcalay, M; Orecchia, R; Natoli, G; Pelicci, P
Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data
2023 Villa, F; Crippa, A; Pelizzoni, D; Ardizzoia, A; Scartabellati, G; Corbetta, C; Cipriani, E; Lavitrano, M; Ardizzoia, A
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells
2023 Cordani, N; Mologni, L; Piazza, R; Cogliati, V; Pepe, F; Capici, S; DI BELLA, C; Jaconi, M; Cerrito, M; Villa, M; Tettamanti, P; Cavaletti, G; Lavitrano, M; Cazzaniga, M
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells
2023 Cordani, N; Mologni, L; Piazza, R; Tettamanti, P; Cogliati, V; Mauri, M; Villa, M; Malighetti, F; Di Bella, C; Jaconi, M; Cerrito, M; Cavaletti, G; Lavitrano, M; Cazzaniga, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile